Patents Assigned to Biovation Ltd.
  • Patent number: 7264806
    Abstract: The present invention provides for modified forms of anti-CD52 antibodies with reduced numbers of potential T-cell epitopes that are expected to display decreased immunogenicity.
    Type: Grant
    Filed: October 29, 2004
    Date of Patent: September 4, 2007
    Assignee: Biovation Ltd.
    Inventors: Francis J. Carr, Anita A. Hamilton